The challenge of peptide nucleic acid synthesis

被引:28
作者
Nandhini, K. P. [1 ,2 ]
Shaer, Danah Al [1 ,2 ]
Albericio, Fernando [2 ,3 ,4 ]
de la Torre, Beatriz G. G. [1 ]
机构
[1] Univ KwaZulu Natal, Coll Hlth Sci, Sch Lab Med & Med Sci, KwaZulu Natal Res Innovat & Sequencing Platform KR, ZA-4041 Durban, South Africa
[2] Univ KwaZulu Natal, Sch Chem & Phys, Peptide Sci Lab, ZA-4000 Durban, South Africa
[3] Univ Barcelona, CIBER BBN, Networking Ctr Bioengn Biomat & Nanomed, Marti I Franques 1-11, Barcelona 08028, Spain
[4] Univ Barcelona, Dept Organ Chem, Marti I Franques 1-11, Barcelona 08028, Spain
基金
新加坡国家研究基金会;
关键词
SOLID-PHASE SYNTHESIS; O-ALLYL PROTECTION; PNA MONOMERS; DIMETHYL-SULFOXIDE; CONVENIENT ROUTE; CELLULAR UPTAKE; N-ALKYLATION; ALPHA-AMINO; DNA; ANALOGS;
D O I
10.1039/d2cs00049k
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Peptide nucleic acids (PNAs) are an important class of DNA/RNA mimics that can hybridize complementary chains of nucleic acids with high affinity and specificity. Because of this property and their metabolic stability, PNAs have broad potential applications in different fields. Consisting of a neutral polyamide backbone, PNAs are prepared following the method used for peptide synthesis. In this regard, they are prepared by the sequential coupling of the protected monomers on a solid support using a similar approach to solid-phase peptide synthesis (SPPS). However, PNA synthesis is a little more challenging due to issues of the difficulty on the preparation of monomers and their solubility. Furthermore, the PNA elongation is jeopardized by intra/inter chain aggregation and side reactions. These hurdles can be overcome using different protecting group strategies on the PNA monomer, which also dictate the approach followed to prepare the oligomers. Herein, the main synthetic strategies driven by the protecting group scheme are discussed. However, there is still ample scope for further enhancement of the overall process.
引用
收藏
页码:2764 / 2789
页数:26
相关论文
共 159 条
[1]   Pseudo-complementary PNA actuators as reversible switches in dynamic DNA nanotechnology [J].
Ackermann, Damian ;
Famulok, Michael .
NUCLEIC ACIDS RESEARCH, 2013, 41 (08) :4729-4739
[2]   From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies [J].
Adachi, Hironori ;
Hengesbach, Martin ;
Yu, Yi-Tao ;
Morais, Pedro .
BIOMEDICINES, 2021, 9 (05)
[3]   2020 FDA TIDES (Peptides and Oligonucleotides) Harvest [J].
Al Musaimi, Othman ;
Al Shaer, Danah ;
Albericio, Fernando ;
de la Torre, Beatriz G. .
PHARMACEUTICALS, 2021, 14 (02) :1-14
[4]  
Albericio F, 2000, BIOPOLYMERS, V55, P123, DOI 10.1002/1097-0282(2000)55:2<123::AID-BIP30>3.0.CO
[5]  
2-F
[6]   O-allyl protection in the Fmoc-based synthesis of difficult PNA [J].
Altenbrunn, Frank ;
Seitz, Oliver .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2008, 6 (14) :2493-2498
[7]  
[Anonymous], About Us
[8]   The impact of nucleic acid secondary structure on PNA hybridization [J].
Armitage, BA .
DRUG DISCOVERY TODAY, 2003, 8 (05) :222-228
[9]   Cyanobacteria Produce N-(2-Aminoethyl)Glycine, a Backbone for Peptide Nucleic Acids Which May Have Been the First Genetic Molecules for Life on Earth [J].
Banack, Sandra Anne ;
Metcalf, James S. ;
Jiang, Liying ;
Craighead, Derek ;
Ilag, Leopold L. ;
Cox, Paul Alan .
PLOS ONE, 2012, 7 (11)
[10]   A 3-DIMENSIONAL ORTHOGONAL PROTECTION SCHEME FOR SOLID-PHASE PEPTIDE-SYNTHESIS UNDER MILD CONDITIONS [J].
BARANY, G ;
ALBERICIO, F .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (17) :4936-4942